Sera Prognostics Current Ratio 2021-2025 | SERA
Sera Prognostics current ratio from 2021 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Sera Prognostics Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $0.05B | $0.02B | 2.02 |
| 2024-12-31 | $0.05B | $0.03B | 1.92 |
| 2024-09-30 | $0.05B | $0.02B | 2.11 |
| 2024-06-30 | $0.05B | $0.03B | 2.08 |
| 2024-03-31 | $0.05B | $0.03B | 2.19 |
| 2023-12-31 | $0.06B | $0.02B | 2.51 |
| 2023-09-30 | $0.05B | $0.01B | 3.51 |
| 2023-06-30 | $0.06B | $0.01B | 4.54 |
| 2023-03-31 | $0.07B | $0.01B | 5.23 |
| 2022-12-31 | $0.09B | $0.02B | 5.80 |
| 2022-09-30 | $0.09B | $0.01B | 10.48 |
| 2022-06-30 | $0.11B | $0.01B | 14.80 |
| 2022-03-31 | $0.11B | $0.01B | 15.77 |
| 2021-12-31 | $0.11B | $0.01B | 13.11 |
| 2021-09-30 | $0.12B | $0.00B | 34.53 |
| 2021-06-30 | $0.09B | $0.00B | 28.27 |
| 2021-03-31 | $0.00B | 0.00 | |
| 2020-12-31 | $0.00B | 0.00 | |
| 2020-09-30 | $0.00B | 0.00 | |
| 2020-06-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.064B | $0.000B |
| Sera Prognostics Inc. is a women's health diagnostics company. It focused on improving maternal and neonatal health by providing pregnancy biomarker information to doctors and patients. Sera Prognostics Inc. is based in SALT LAKE CITY. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.613B | 26.99 |
| Elevance Health (ELV) | United States | $86.883B | 10.98 |
| CVS Health (CVS) | United States | $85.338B | 10.65 |
| Cencora (COR) | United States | $57.283B | 19.72 |
| DiDi Global (DIDIY) | China | $22.826B | 24.05 |
| Natera (NTRA) | United States | $22.577B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.856B | 17.92 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.669B | 0.00 |
| Solventum (SOLV) | United States | $12.768B | 13.64 |
| ICON (ICLR) | Ireland | $11.763B | 11.04 |
| CochLear (CHEOY) | Australia | $11.550B | 0.00 |
| Revvity (RVTY) | United States | $11.024B | 19.54 |
| Doximity (DOCS) | United States | $10.503B | 48.66 |
| Viatris (VTRS) | United States | $10.469B | 3.62 |
| HealthEquity (HQY) | United States | $9.059B | 38.29 |
| Avantor (AVTR) | United States | $8.906B | 13.30 |
| Medpace Holdings (MEDP) | United States | $8.572B | 22.98 |
| Sonic Healthcare (SKHHY) | Australia | $8.393B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.340B | 14.54 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.361B | 25.42 |
| BrightSpring Health Services (BTSG) | United States | $3.724B | 34.39 |
| Sotera Health (SHC) | United States | $3.244B | 18.26 |
| Alignment Healthcare (ALHC) | United States | $2.956B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.914B | 38.62 |
| Concentras Parent (CON) | United States | $2.749B | 15.81 |
| Organon (OGN) | United States | $2.610B | 2.81 |
| Ardent Health (ARDT) | United States | $1.881B | 7.88 |
| Premier (PINC) | United States | $1.858B | 13.94 |
| GeneDx Holdings (WGS) | United States | $1.842B | 73.50 |
| Progyny (PGNY) | United States | $1.803B | 39.74 |
| PACS (PACS) | United States | $1.573B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.561B | 31.64 |
| Teladoc Health (TDOC) | United States | $1.203B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.203B | 9.03 |
| Establishment Labs Holdings (ESTA) | $1.083B | 0.00 | |
| CareDx (CDNA) | United States | $1.035B | 16.58 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.890B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.826B | 7.85 |
| QDM (QDMI) | Hong Kong, SAR China | $0.763B | 0.00 |
| Nutex Health (NUTX) | United States | $0.679B | 11.25 |
| LifeMD (LFMD) | United States | $0.566B | 0.00 |
| Embecta (EMBC) | United States | $0.559B | 3.95 |
| Enhabit (EHAB) | United States | $0.495B | 41.42 |
| InnovAge Holding (INNV) | United States | $0.478B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.467B | 10.57 |
| SBC Medicals (SBC) | United States | $0.459B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.453B | 0.00 |
| Omada Health (OMDA) | $0.440B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.411B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.255B | 0.00 |
| Oncology Institute (TOI) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.193B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 25.67 |
| Pheton Holdings (PTHL) | China | $0.114B | 0.00 |
| So-Young (SY) | China | $0.097B | 0.00 |
| KindlyMD (NAKA) | United States | $0.083B | 0.00 |
| OncoCyte (OCX) | United States | $0.076B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| Biodesix (BDSX) | United States | $0.042B | 0.00 |
| ModivCare (MODV) | United States | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |